EMAIL THIS PAGE TO A FRIEND

PloS one

Mycobacterium tuberculosis multidrug resistant strain M induces an altered activation of cytotoxic CD8+ T cells.


PMID 24836916

Abstract

In human tuberculosis (TB), CD8+ T cells contribute to host defense by the release of Th1 cytokines and the direct killing of Mycobacterium tuberculosis (Mtb)-infected macrophages via granule exocytosis pathway or the engagement of receptors on target cells. Previously we demonstrated that strain M, the most prevalent multidrug-resistant (MDR) Mtb strain in Argentine, is a weak inducer of IFN-γ and elicits a remarkably low CD8-dependent cytotoxic T cell activity (CTL). In contrast, the closely related strain 410, which caused a unique case of MDR-TB, elicits a CTL response similar to H37Rv. In this work we extend our previous study investigating some parameters that can account for this discrepancy. We evaluated the expressions of the lytic molecules perforin, granzyme B and granulysin and the chemokine CCL5 in CD8+ T cells as well as activation markers CD69 and CD25 and IL-2 expression in CD4+ and CD8+ T cells stimulated with strains H37Rv, M and 410. Our results demonstrate that M-stimulated CD8+ T cells from purified protein derivative positive healthy donors show low intracellular expression of perforin, granzyme B, granulysin and CCL5 together with an impaired ability to form conjugates with autologous M-pulsed macrophages. Besides, M induces low CD69 and IL-2 expression in CD4+ and CD8+ T cells, being CD69 and IL-2 expression closely associated. Furthermore, IL-2 addition enhanced perforin and granulysin expression as well as the degranulation marker CD107 in M-stimulated CD8+ T cells, making no differences with cells stimulated with strains H37Rv or 410. Thus, our results highlight the role of IL-2 in M-induced CTL activity that drives the proper activation of CD8+ T cells as well as CD4+ T cells collaboration.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2701008
Anti-CCL5 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
R125 Anti-RANTES antibody produced in goat, affinity isolated antibody, lyophilized powder
SRP3242 IL-2 from rat, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
SAB4700364 Monoclonal Anti-CD25-PE antibody produced in mouse, clone MEM-181, purified immunoglobulin, buffered aqueous solution
SAB4700577 Monoclonal Anti-CD25-PE antibody produced in rat, clone PC61.5.3, purified immunoglobulin, buffered aqueous solution
SAB4700332 Monoclonal Anti-CD54-FITC antibody produced in mouse, clone 1H4, purified immunoglobulin, buffered aqueous solution
SAB4700573
Monoclonal Anti-CD54-FITC antibody produced in rat, clone YN1/1.7.4, purified immunoglobulin, buffered aqueous solution
SAB4700328 Monoclonal Anti-CD54-PE antibody produced in mouse, clone MEM-111, purified immunoglobulin, buffered aqueous solution
SAB4700333
Monoclonal Anti-CD54-PE antibody produced in mouse, clone 1H4, purified immunoglobulin, buffered aqueous solution
SAB4700492 Monoclonal Anti-CD62L-PE antibody produced in mouse, clone LT-TD180, purified immunoglobulin, buffered aqueous solution
SAB4700222 Monoclonal Anti-CD69-PE antibody produced in mouse, clone FN50, purified immunoglobulin, buffered aqueous solution
SAB4700088
Monoclonal Anti-CD8-PE antibody produced in mouse, clone MEM-31, purified immunoglobulin, buffered aqueous solution
P5560 Monoclonal Anti-CD8−PE antibody produced in mouse, clone UCHT-4, purified immunoglobulin, buffered aqueous solution
SAB4700566 Monoclonal Anti-Cd8a-PE antibody produced in rat, clone 53-6.7, purified immunoglobulin, buffered aqueous solution
R9400 Monoclonal Anti-RANTES antibody produced in rat, clone 53405.111, purified immunoglobulin, lyophilized powder